Clinical Trial Update: A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of AXR-159 ophthalmic solution for dry eye disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• AXR-159

Snippet

Sponsor: AxeroVision, Inc. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2023-10-13